Cargando…
Long-term combination therapy with Metformin and Oxymetholone in a Fanconi Anemia mouse model
Fanconi Anemia (FA) is a disease caused by defective DNA repair which manifests as bone marrow failure, cancer predisposition, and developmental defects. Mice containing inactivating mutations in one or more genes in the FA pathway partially mimic the human disease. We previously reported that monot...
Autores principales: | Dorrell, Craig, Peters, Alexander M, Zhang, Qingshuo, Balaji, Niveditha, Baradar, Kevin, Mochizuki-Kashio, Makiko, Major, Angela, Finegold, Milton, Liu, Chih-Wei, Lu, Kun, Grompe, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465065/ https://www.ncbi.nlm.nih.gov/pubmed/37649908 http://dx.doi.org/10.1101/2023.08.16.553572 |
Ejemplares similares
-
Oxymetholone Therapy of Fanconi Anemia Suppresses Osteopontin Transcription and Induces Hematopoietic Stem Cell Cycling
por: Zhang, Qing-Shuo, et al.
Publicado: (2014) -
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
por: Pollard, Jessica A., et al.
Publicado: (2022) -
Adult Mouse Liver Contains Two Distinct Populations of Cholangiocytes
por: Li, Bin, et al.
Publicado: (2017) -
Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis
por: Pengthina, Worachaya, et al.
Publicado: (2022) -
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
por: Shen, Yihang, et al.
Publicado: (2015)